Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study.
Tiffany C LeeKoffi WimaJeffrey J SussmanSyed A AhmadJordan M CloydAhmed AhmedKeith FournierAndrew J LeeSean DineenBenjamin PowersJula VeerapongJoel M BaumgartnerCallisia ClarkeHarveshp MogalMohammad Y ZaidiShishir K MaithelJennifer LeitingTravis GrotzLaura LambertRyan J HendrixDaniel E AbbottCourtney PokrzywaAndrew M BlakelyByrne LeeFabian M JohnstonJonathan GreerSameer H PatelPublished in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2019)
In the largest study to date examining readmissions after CRS-HIPEC, 30-day readmission rate was 15.9%. Tumor factors failed to predict readmission, whereas preoperative functional status and depression along with individual cytoreductive procedures predicted readmission. Patients with these risk factors or postoperative complications may benefit from closer post-discharge monitoring.